Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program.
Asgari-Targhi A, Yao B, Brown L, Garcia S, Nagendra A, Chin K, Billah T, Penzel N, John O, Prunier N, Veale S, Kotler E, Jacobs GR, Zhan M, Coleman MJ, Bouix S, Pasternak O, Cecci G, Baker JT, Mathalon DH, Kelly SM, Corcoran CM, Reichenberg A, Winter-van Rossum I, Kubicki M, Spark J, Dwyer D, Arango C, Fusar-Poli P, Calkins M, Shah JL, Mittal V, Thompson A, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Nelson B, Shenton ME, Staglin B; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Larrauri CA, Lewandowski KE, Kapur T.
Asgari-Targhi A, et al. Among authors: kubicki m.
Schizophrenia (Heidelb). 2025 Apr 7;11(1):57. doi: 10.1038/s41537-025-00572-7.
Schizophrenia (Heidelb). 2025.
PMID: 40195300
Free PMC article.